RecruitingNCT06009718

Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG)

A Deep-learning-based Multi-modal Phonocardiogram(PCG) and Electrocardiogram(ECG) Processing Framework for Screening Depressed Left Ventricular Ejection Fraction (dLVEF) Using a Wearable Cardiac Patch


Sponsor

Ruijin Hospital

Enrollment

3,000 participants

Start Date

Aug 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The diagnosis of depressed left ventricular ejection fraction (dLVEF) (EF\<50%) depends on golden standard ultrasound cardiography (UCG). A wearable synchronized phonocardiography (PCG) and electrocardiogram (ECG) device can assist in the diagnosis of dLVEF, which can both expedite access to life-saving therapies and reduce the need for costly testing.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria6

  • Attendance at RuiJin hospital for UCG
  • Signed dated informed consent
  • Commit to follow the research procedures and cooperate in the implementation of the whole process research
  • UCG has been completed
  • Age ≥ 18
  • At least 8 consecutive cycles of sinus rhythm can be recorded

Exclusion Criteria4

  • Patients with pacemakers
  • Complete left bundle branch block or block or QRS wave widening\>120ms
  • Left chest skin damaged or allergic to patch
  • Refusal to participate

Locations(3)

Ruijin Hospital, Shanghai Jiaotong School of Medicine

Shanghai, China

Shanghai Chest Hospital, Shanghai Jiao Tong University School Of Medicine

Shanghai, China

Shanghai East Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06009718


Related Trials